Bispectral Index (BIS) Versus Electronic Alerts in the Prevention of Anesthesia Awareness: the Michigan Awareness Control Study (MACS)

November 3, 2017 updated by: George Mashour, University of Michigan

A Prospective, Randomized, Controlled Trial Comparing Bispectral Index Monitoring to Electronic Alerts for Prevention of Awareness During Anesthesia in the General Population

Awareness during anesthesia is a problem receiving increased attention by patients, clinicians, and the general public. The incidence of intraoperative awareness has been reported to be between 1-2/1000 cases, but recent data suggest that this may be an overestimate. The Bispectral Index (BIS) Monitor is an electroencephalographic method of assessing depth of anesthesia that has been shown in one study to reduce the incidence of awareness during anesthesia in the high-risk population (Myles et al, 2004). In the study of Myles et al, the number needed to treat (NNT) in order to prevent one case of awareness in the high-risk population was 138, with an associated cost of approximately US$2200. Since the NNT and the associated cost of treatment would be much higher in the general population, the efficacy of the BIS monitor in preventing awareness in all anesthetized patients needs to be clearly established. Furthermore, recent data suggest that the BIS may not be useful in the high-risk population. The investigators propose a prospective, randomized, controlled trial comparing the BIS monitor to electronic alerts based on non-electroencephalographic gauges of anesthetic depth.

Study Overview

Detailed Description

Electronic alerts have been developed and employed at our institution and have been shown to increase compliance with both clinical and administrative tasks (O'Reilly et al, 2006; Kheterpal et al, 2007). The investigators have developed electronic alerts for the purpose of informing the clinician of potentially insufficient anesthesia based on minimum alveolar concentration (MAC). The algorithm is as follows:

  • Every 5 minutes the alerting system checks every active case in our operating rooms. It takes approximately 1 second for this scan of all active cases to occur.
  • Conditions for an "active case" are:

    1. data capture is possible (i.e., not a paper record)
    2. data capture is active (i.e., "patient in room" has been electronically entered and end-tidal [Et] CO2 is detected)
    3. case has been identified as a general anesthetic
    4. "anesthesia induction end" has already been documented
    5. request for recovery room bed or transport to an intensive care unit has not been documented
    6. surgical dressing completion has not been documented
  • The alerting system checks the most recent value (within a specified time period) of:

    1. Et Sevoflurane (MAC=2.0)
    2. Et Isoflurane (MAC=1.2)
    3. Et Desflurane (MAC=6)
    4. Et Nitrous Oxide (MAC=105) and compares it to the MAC of each agent. It adds the resulting MAC values together for "current total MAC."
  • The system then checks for a charted propofol infusion in mcg/kg/min and divides by 150, assuming that 150 mcg/kg/min is "1.0 MAC" for propofol. The analogous concept of MAC for propofol is "Cp50"- the plasma or blood concentrations at which 50% of patients do not move in response to a noxious stimulus. Since the investigators do not have the technology at our institution to calculate Cp50 or Cp50-awake, the investigators have chosen the above propofol dose as an initial value based on clinical experience. The resultant MAC equivalent is added to current total MAC.
  • The system next checks for a dexmedetomidine infusion with a rate of 0.2 mcg/kg/hour or greater. If present, it multiplies the current total inhalational MAC by 2, as dexmedetomidine can reduce MAC by 50%.
  • At this point, the "current total MAC" is defined as: Et Sevo /2 + Et Iso /1.2 + Et Des/6 + Et Nitrous /105 + propofol rate (in mcg/kg/min)/150. If dexmedetomidine is >0.2 mcg/kg/hour, inhalational MAC is multiplied by 2.
  • If this total mac < 0.50, it checks to see if a bolus of propofol, midazolam, etomidate, or thiopental has been given in the preceding 10 minutes.
  • It alerts the clinician signed into the case within 30-60 seconds if total age-adjusted MAC < 0.50 AND no bolus has been documented in the last 10 minutes.

This will be the protocol in the MAC-guided group. In the BIS-guided group an electronic alert will be sent if the BIS value is >60. If an alert is triggered, the clinician electronically signed into the case receives an alphanumeric page stating "Potentially insufficient anesthesia, please check vaporizers and intravenous lines."

The investigators are collaborating with Washington University, the University of Chicago, and the University of Mannitoba, who will also be testing a MAC-based protocol in comparison to the BIS.

Study Type

Interventional

Enrollment (Actual)

22185

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan Medical School, University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • At least 18 years of age, English-speaking, available for follow-up interview at one month.

Exclusion Criteria:

  • Pre-existing neurologic or neuropsychiatric condition, surgical manipulation around forehead, not available for follow-up interview.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: BIS group
This group will have BIS values visible and will receive alerts when the value is >60.
Comparison of two different alerting protocols. One using the bispectral index monitor and one using the MAC alerting protocols.
Active Comparator: MAC Alert
This group will receive an alert if total MAC (including intravenous infusions) is <0.5 age-adjusted.
Comparison of two different alerting protocols. One using the bispectral index monitor and one using the MAC alerting protocols.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Percentage of Incidences With Explicit Recall in the BIS Versus MAC Alert Groups.
Time Frame: Outcome of awareness is assessed 30-days after the operation
By modified intention-to-treat analysis
Outcome of awareness is assessed 30-days after the operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants With Dreams During Anesthesia Compared Between MAC or BIS Monitoring
Time Frame: During surgery (45 minutes - 18 hours), measured based on 30 day interviews
Binary variables for whether participants recall dreaming or not.
During surgery (45 minutes - 18 hours), measured based on 30 day interviews
Percentage of Cases With Electronic Alerts
Time Frame: During surgery: (45 minutes - 18 hours)
During surgery: (45 minutes - 18 hours)
Overall Use of Anesthetics Comparing the BIS to MAC Alerts.
Time Frame: During surgery (45 minutes - 18 hours)
During surgery (45 minutes - 18 hours)
Time Till Discharge Readiness
Time Frame: During recovery room stay: 30 minutes to 6 hours
measured in time within Post Anesthesia Care Unit ( PACU) until the participant is ready for discharge from PACU based on a composite of factors, including pain and neurologic status
During recovery room stay: 30 minutes to 6 hours
Number of Participants Without Nausea or Vomiting
Time Frame: During recovery room stay: 30 minutes to 6 hours
During recovery room stay: 30 minutes to 6 hours
Comparison of the Prospective and Retrospective Approaches to the Study Awareness Incidence.
Time Frame: 30 days after surgery
There is controversy regarding the appropriate technique for assessing awareness during anesthesia with explicit recall. A total cohort was utilized to compare the incidence of awareness with recall as determined by formal interview vs. the incidence of awareness with recall based on spontaneous reports (in the same cohort).
30 days after surgery

Other Outcome Measures

Outcome Measure
Time Frame
Relationship Between BIS Values and Hemodynamic Parameters.
Time Frame: Outcome of hemodynamic stability is assessed
Outcome of hemodynamic stability is assessed
The Relationship Between Cumulative Deep Hypnotic Time, Anesthetic Doses, and Mortality.
Time Frame: Outcome of mortality is assessed
Outcome of mortality is assessed
Predictors of Post-traumatic Stress Disorder Based on the Type of Awareness Event.
Time Frame: Outcome of post-traumatic stress disorder is assessed with the covariate of awareness
Outcome of post-traumatic stress disorder is assessed with the covariate of awareness
Anesthetic Induction Doses, Hypotension, and BIS Values.
Time Frame: Outcome of hypotension in relationship to induction doses and BIS values will be assessed
Outcome of hypotension in relationship to induction doses and BIS values will be assessed
Meta-Analysis of Awareness Events in Conjunction With the BAG-RECALL Study Based at Washington University.
Time Frame: Outcome of awareness is assessed
Outcome of awareness is assessed
Incidence of Post-traumatic Stress Disorder.
Time Frame: NEED VALUE HERE
NEED VALUE HERE

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2008

Primary Completion (Actual)

April 1, 2010

Study Completion (Actual)

June 1, 2010

Study Registration Dates

First Submitted

May 29, 2008

First Submitted That Met QC Criteria

May 29, 2008

First Posted (Estimate)

June 3, 2008

Study Record Updates

Last Update Posted (Actual)

December 7, 2017

Last Update Submitted That Met QC Criteria

November 3, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • HUM00013626

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Awareness During General Anesthesia

Clinical Trials on Bispectral Index Monitor

3
Subscribe